Intrapartum Glucose and Insulin Compared to Glucose Alone in Diabetic Women

• Status: Recruiting
• Trial end date: 2021-05-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study aims to examine the effect of intrapartum treatment of diabetic women with combined glucose and constant insulin infusion compared to glucose alone on the incidence of neonatal hypoglycemia. Pregnant women with diabetes in pregnancy will be randomly divided during labor to 2 groups: group 1, will receive intravenous glucose with constant insulin infusion; group 2 will receive intravenous glucose alone. The primary outcome is the incidence of neonatal hypoglycemia.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: HaEmek Medical Center, Israel
• Treatments: Insulin; Insulin, Globin Zinc; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• >37 weeks gestation

• gestational diabetes mellitus according to Carpenter and Coustan

• pregestational diabetes mellitus

Exclusion Criteria:

• Intrauterine fetal death

• estimated fetal weight<10p

• multiple gestation

• major fetal malformations